OPHTHOTECH CORP's ticker is OPHT and the CUSIP is 683745103. A total of 73 filers reported holding OPHTHOTECH CORP in Q2 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $16,000 | -5.9% | 6,000 | 0.0% | 0.01% | -10.0% |
Q1 2018 | $17,000 | -10.5% | 6,000 | 0.0% | 0.01% | -28.6% |
Q4 2017 | $19,000 | +11.8% | 6,000 | 0.0% | 0.01% | +7.7% |
Q3 2017 | $17,000 | +6.2% | 6,000 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $16,000 | -27.3% | 6,000 | 0.0% | 0.01% | -27.8% |
Q1 2017 | $22,000 | -24.1% | 6,000 | 0.0% | 0.02% | -28.0% |
Q4 2016 | $29,000 | – | 6,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,103,981 | $44,734,000 | 25.02% |
Novo Holdings A/S | 4,910,487 | $198,973,000 | 20.56% |
JHL Capital Group LLC | 3,265,000 | $132,298,000 | 14.62% |
AlpInvest Partners B.V. | 111,519 | $4,519,000 | 8.90% |
Opaleye Management Inc. | 105,000 | $4,255,000 | 2.09% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 16,110 | $653,000 | 2.05% |
IMA Wealth, Inc. | 66,061 | $2,623,000 | 1.66% |
WILLIAM HARRIS INVESTORS INC | 143,022 | $5,795,000 | 1.64% |
Orbimed Advisors | 1,923,500 | $77,940,000 | 0.79% |
Overbrook Management Corp | 117,807 | $4,774,000 | 0.74% |